Breakthrough offers major Alzheimer's target; viral link between leukemia and prostate cancer;

Genetic Research

Scientists at Britain's Cardiff University say they have found three new genetic links to Alzheimer's that play a role in 20 percent of all cases. And they touted their discovery as the most important breakthrough in Alzheimer's research in the past 15 years. "If we were able to remove the detrimental effects of these genes through treatments, we could reduce the proportion of people developing Alzheimer's by 20 percent," says Julie Williams. Story

Linda Avey, the co-founder of 23andMe, has left the start-up to launch a new foundation that will use the company's genetic research technology to find new therapies for the disease. Report

Researchers say that the H1N1 virus doesn't appear to seek out new genes that could make it more lethal. Story

Cancer Research

A new study has found a viral link between leukemia in animals and prostate cancer, pointing to the need for a new vaccine and screening. The virus was found in about a quarter of all prostate cancer samples. Story

UCSF researchers have developed a new approach to identify specific genes that influence how cancer cells respond to drugs and how they become resistant. Release

A common weed called American mayapple may soon offer an alternative to an Asian cousin that's been harvested almost to extinction because of its anti-cancer properties. Release

Stem Cell Research

A group of doctors, lawyers and ethicists is calling for more effective regulation of stem cell research in order to clamp down on the hype that often spurs patients to get unproven therapies. Report

BioTime announced today that Walter Funk, Ph.D. has joined its management team as vice president for stem cell research. Release

Brainstorm Cell Therapeutics has struck a production deal with Protein Production Services. Report

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.